exit_to_appLogin
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Signup
Frontpage iOS AppFrontpage Android App
forum

BAFNAPHARM Share Price Discussion

Bafna Pharmaceuticals Ltd.
Sector: Pharmaceuticals and health care
... Read more
BAFNAPHARM Share Price *
0 +0 (0%)
* (quote may be delayed)

Find answers to all your questions on live BAFNAPHARM message board: Is BAFNAPHARM buy or sell? Should I buy BAFNAPHARM shares? Why are BAFNAPHARM shares falling? Should I invest in BAFNAPHARM stock?


BAFNAPHARM Discussion Forum

hourglass_empty
No posts yet.
This service may be new or inactive. Please check back later.

  • BAFNAPHARM - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization66.25
    Enterprise Value110.09
    Price to Earnings9.01
    Price to Book Value1.63
    Return on Capital Employed-0.09
    Return on Equity-0.41
    Face Value10
    Dividend YieldNA

  • BAFNAPHARM Share Price - Technicals

    keyboard_arrow_down
    BAFNAPHARM - 52 Week High₹21.85
    BAFNAPHARM - 52 Week Low₹7.5

  • BAFNAPHARM Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    May 3113.213.210.9511.1
    May 3011.4121112
    May 298.610.05810
    May 288.28.57.78.4
    May 278.38.37.958.2

  • BAFNAPHARM Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹8.51
    30 Day Moving Average₹8.67
    50 Day Moving Average₹9.18
    100 Day Moving Average₹9.78
    200 Day Moving Average₹12.5

  • BAFNAPHARM - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue75.664.960.16
    Operating Profit-5.05-5.22-0.03
    Profit Before Tax-14.28-19.3-0.26
    Net Income-16.45-18.47-0.11

  • BAFNAPHARM - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds40.5340.98-0.01
    Total Liabilities86.98126.17-0.31
    Total Assets127.51167.15-0.24

  • BAFNAPHARM - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity-13.134.34-4.03
    Cash from Investing Activity37.791.0634.65
    Cash from Financing Activity-30.65-5.434.64
    Net Cash Flow-5.98-0.04148.5

  • BAFNAPHARM - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets-0.13-0.11
    Return on Equity-0.41-0.45
    Return on Capital Employed-0.09-0.06

  • BAFNAPHARM - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.25
    3 Year CAGR Growth in Operating Profit0.73
    3 Year CAGR Growth in EBIDTA-1.16
    3 Year CAGR Growth in Net Income-3.69
    3 Yr CAGR Growth - Diluted EPS-3.12

  • BAFNAPHARM - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.55
    5 Year CAGR Growth in Operating Profit-1.24
    5 Year CAGR Growth in EBIDTA-1.16
    5 Year CAGR Growth in Net Income-5.24
    3 Yr CAGR Growth - Diluted EPS-4.34

  • BAFNAPHARM - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.
FrontPage Apps
Frontpage iOS AppFrontpage Android App
HelpAboutPrivacyTermsDisclaimersRefunds